Literature DB >> 34976285

Maintenance Phototherapy for the Treatment of Early-stage Mycosis Fungoides.

Soumaya Gara1, Noureddine Litaiem1, Takwa Bacha1, Yosra Jmour1, Faten Zeglaoui1.   

Abstract

Mycosis fungoides (MF) is the most common type of cutaneous T cell lymphoma. Phototherapy is a first-line treatment option of early stages MF. The present study aimed at assessing the efficacy of phototherapy in Tunisian patients with MF treated with phototherapy and evaluate the efficacy of maintenance phase.
Copyright © 2021. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Mycosis fungoides; NBUVB therapy; PUVA therapy; maintenance phase

Year:  2021        PMID： 34976285      PMCID： PMC8711619     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


  5 in total

1.  Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.

Authors:  Mohammad Almohideb; Sandra Walsh; Scott Walsh; Neil Shear; Raed Alhusayen
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2017-06-19

2.  Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial.

Authors:  Pablo Vieyra-Garcia; Regina Fink-Puches; Stefanie Porkert; Roland Lang; Sophie Pöchlauer; Gudrun Ratzinger; Adrian Tanew; Sylvia Selhofer; Sator Paul-Gunther; Angelika Hofer; Alexandra Gruber-Wackernagel; Franz Legat; Vijaykumar Patra; Franz Quehenberger; Lorenzo Cerroni; Rachael Clark; Peter Wolf
Journal:  JAMA Dermatol       Date:  2019-05-01       Impact factor: 10.282

3.  Is PUVA maintenance therapy necessary in patients with early-stage mycosis fungoides? Evaluation of a treatment guideline over a 28-month follow-up.

Authors:  María A Sánchez; Tatiana González; Miguel F Gaitán; Angela Zuluaga; Sol B Jiménez; Yolanda T de Galvis
Journal:  Int J Dermatol       Date:  2011-03-07       Impact factor: 2.736

Review 4.  Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian Task Force for Cutaneous Lymphomas.

Authors:  V Grandi; P Fava; S Rupoli; S Alberti Violetti; L Canafoglia; P Quaglino; E Berti; N Pimpinelli
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-01-29       Impact factor: 6.166

5.  Treatment of stage Ia and Ib mycosis fungoides with psoralen UVA monotherapy: an observational study in tertiary hospitals in the Canary Islands.

Authors:  Zaida Hernández; Yeray Peñate; Buenaventura Hernández-Machín; Lina Pérez-Méndez; Jose Suárez-Hernández; Javier Hernández; Ricardo Fernández-de-Misa
Journal:  Int J Dermatol       Date:  2014-04-02       Impact factor: 2.736
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.